Effect of Ishige okamurae extract on musculoskeletal biomarkers in adults with relative sarcopenia: Study protocol for a randomized double-blind placebo-controlled trial
IntroductionSarcopenia is a phenomenon in which skeletal muscle mass decreases with age, causing many health problems. Many studies have been conducted to improve sarcopenia nutritionally. Ishige okamura (IO) is a genus of brown algae and plays a role in anti-diabetes, anti-obesity, and myogenesis....
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-09-01
|
Series: | Frontiers in Nutrition |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fnut.2022.1015351/full |
_version_ | 1798001411052535808 |
---|---|
author | Sae Rom Lee Ye Li Lee Sang Yeoup Lee Sang Yeoup Lee Sang Yeoup Lee |
author_facet | Sae Rom Lee Ye Li Lee Sang Yeoup Lee Sang Yeoup Lee Sang Yeoup Lee |
author_sort | Sae Rom Lee |
collection | DOAJ |
description | IntroductionSarcopenia is a phenomenon in which skeletal muscle mass decreases with age, causing many health problems. Many studies have been conducted to improve sarcopenia nutritionally. Ishige okamura (IO) is a genus of brown algae and plays a role in anti-diabetes, anti-obesity, and myogenesis. However, the effect of IO extract (IOE) on human muscle strength and mass is unclear. Therefore, we will examine the impact and safety of consumption of IOE for 12 weeks on muscle strength and mass in middle-aged and old-aged adults with relatively low skeletal muscle mass.Materials and methodsA randomized controlled trial is conducted on 80 adults aged 50–80. A total of 80 participants will be enrolled in this study. Participants assign IOE-taking group (n = 40) and placebo taking group (n = 40). At a baseline and 12 weeks after treatment, the following parameters of the participants are checked: knee extension strength, handgrip strength, body composition, laboratory tests, dietary recall, physical activity, and EQ-5D-5L.DiscussionThe present study will be the first randomized, double-blind placebo-controlled trial to examine the efficacy and tolerability of IOE supplementation in adults with relatively low muscle mass. The nutritional intake and physical activity that might influence muscle strength and mass will be considered as covariates for transparency of results. The results of this study will provide clinical evidence for sarcopenia patients with nutrient treatment.Clinical Trial Registrationwww.clinicaltrials.gov/, Identifier: NCT04617951. |
first_indexed | 2024-04-11T11:35:53Z |
format | Article |
id | doaj.art-80513184e08349d3a284d5cdd1ff9ec9 |
institution | Directory Open Access Journal |
issn | 2296-861X |
language | English |
last_indexed | 2024-04-11T11:35:53Z |
publishDate | 2022-09-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Nutrition |
spelling | doaj.art-80513184e08349d3a284d5cdd1ff9ec92022-12-22T04:25:58ZengFrontiers Media S.A.Frontiers in Nutrition2296-861X2022-09-01910.3389/fnut.2022.10153511015351Effect of Ishige okamurae extract on musculoskeletal biomarkers in adults with relative sarcopenia: Study protocol for a randomized double-blind placebo-controlled trialSae Rom Lee0Ye Li Lee1Sang Yeoup Lee2Sang Yeoup Lee3Sang Yeoup Lee4Family Medicine Clinic and Biomedical Research Institute, Pusan National University Yangsan Hospital, Yangsan, South KoreaIntegrated Research Institute for Natural Ingredients and Functional Foods, Yangsan, South KoreaFamily Medicine Clinic and Biomedical Research Institute, Pusan National University Yangsan Hospital, Yangsan, South KoreaIntegrated Research Institute for Natural Ingredients and Functional Foods, Yangsan, South KoreaDepartment of Medical Education, Pusan National University School of Medicine, Yangsan, South KoreaIntroductionSarcopenia is a phenomenon in which skeletal muscle mass decreases with age, causing many health problems. Many studies have been conducted to improve sarcopenia nutritionally. Ishige okamura (IO) is a genus of brown algae and plays a role in anti-diabetes, anti-obesity, and myogenesis. However, the effect of IO extract (IOE) on human muscle strength and mass is unclear. Therefore, we will examine the impact and safety of consumption of IOE for 12 weeks on muscle strength and mass in middle-aged and old-aged adults with relatively low skeletal muscle mass.Materials and methodsA randomized controlled trial is conducted on 80 adults aged 50–80. A total of 80 participants will be enrolled in this study. Participants assign IOE-taking group (n = 40) and placebo taking group (n = 40). At a baseline and 12 weeks after treatment, the following parameters of the participants are checked: knee extension strength, handgrip strength, body composition, laboratory tests, dietary recall, physical activity, and EQ-5D-5L.DiscussionThe present study will be the first randomized, double-blind placebo-controlled trial to examine the efficacy and tolerability of IOE supplementation in adults with relatively low muscle mass. The nutritional intake and physical activity that might influence muscle strength and mass will be considered as covariates for transparency of results. The results of this study will provide clinical evidence for sarcopenia patients with nutrient treatment.Clinical Trial Registrationwww.clinicaltrials.gov/, Identifier: NCT04617951.https://www.frontiersin.org/articles/10.3389/fnut.2022.1015351/fulldietary supplementssarcopeniaIshige okamuraemusclerandomized clinical trialadult |
spellingShingle | Sae Rom Lee Ye Li Lee Sang Yeoup Lee Sang Yeoup Lee Sang Yeoup Lee Effect of Ishige okamurae extract on musculoskeletal biomarkers in adults with relative sarcopenia: Study protocol for a randomized double-blind placebo-controlled trial Frontiers in Nutrition dietary supplements sarcopenia Ishige okamurae muscle randomized clinical trial adult |
title | Effect of Ishige okamurae extract on musculoskeletal biomarkers in adults with relative sarcopenia: Study protocol for a randomized double-blind placebo-controlled trial |
title_full | Effect of Ishige okamurae extract on musculoskeletal biomarkers in adults with relative sarcopenia: Study protocol for a randomized double-blind placebo-controlled trial |
title_fullStr | Effect of Ishige okamurae extract on musculoskeletal biomarkers in adults with relative sarcopenia: Study protocol for a randomized double-blind placebo-controlled trial |
title_full_unstemmed | Effect of Ishige okamurae extract on musculoskeletal biomarkers in adults with relative sarcopenia: Study protocol for a randomized double-blind placebo-controlled trial |
title_short | Effect of Ishige okamurae extract on musculoskeletal biomarkers in adults with relative sarcopenia: Study protocol for a randomized double-blind placebo-controlled trial |
title_sort | effect of ishige okamurae extract on musculoskeletal biomarkers in adults with relative sarcopenia study protocol for a randomized double blind placebo controlled trial |
topic | dietary supplements sarcopenia Ishige okamurae muscle randomized clinical trial adult |
url | https://www.frontiersin.org/articles/10.3389/fnut.2022.1015351/full |
work_keys_str_mv | AT saeromlee effectofishigeokamuraeextractonmusculoskeletalbiomarkersinadultswithrelativesarcopeniastudyprotocolforarandomizeddoubleblindplacebocontrolledtrial AT yelilee effectofishigeokamuraeextractonmusculoskeletalbiomarkersinadultswithrelativesarcopeniastudyprotocolforarandomizeddoubleblindplacebocontrolledtrial AT sangyeouplee effectofishigeokamuraeextractonmusculoskeletalbiomarkersinadultswithrelativesarcopeniastudyprotocolforarandomizeddoubleblindplacebocontrolledtrial AT sangyeouplee effectofishigeokamuraeextractonmusculoskeletalbiomarkersinadultswithrelativesarcopeniastudyprotocolforarandomizeddoubleblindplacebocontrolledtrial AT sangyeouplee effectofishigeokamuraeextractonmusculoskeletalbiomarkersinadultswithrelativesarcopeniastudyprotocolforarandomizeddoubleblindplacebocontrolledtrial |